Department of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Medical Genomics Center, Nagoya University Hospital, Nagoya, Japan.
Transl Psychiatry. 2020 Dec 5;10(1):421. doi: 10.1038/s41398-020-01107-7.
Dysregulation of epigenetic processes involving histone methylation induces neurodevelopmental impairments and has been implicated in schizophrenia (SCZ) and autism spectrum disorder (ASD). Variants in the gene encoding lysine demethylase 4C (KDM4C) have been suggested to confer a risk for such disorders. However, rare genetic variants in KDM4C have not been fully evaluated, and the functional impact of the variants has not been studied using patient-derived cells. In this study, we conducted copy number variant (CNV) analysis in a Japanese sample set (2605 SCZ and 1141 ASD cases, and 2310 controls). We found evidence for significant associations between CNVs in KDM4C and SCZ (p = 0.003) and ASD (p = 0.04). We also observed a significant association between deletions in KDM4C and SCZ (corrected p = 0.04). Next, to explore the contribution of single nucleotide variants in KDM4C, we sequenced the coding exons in a second sample set (370 SCZ and 192 ASD cases) and detected 18 rare missense variants, including p.D160N within the JmjC domain of KDM4C. We, then, performed association analysis for p.D160N in a third sample set (1751 SCZ and 377 ASD cases, and 2276 controls), but did not find a statistical association with these disorders. Immunoblotting analysis using lymphoblastoid cell lines from a case with KDM4C deletion revealed reduced KDM4C protein expression and altered histone methylation patterns. In conclusion, this study strengthens the evidence for associations between KDM4C CNVs and these two disorders and for their potential functional effect on histone methylation patterns.
表观遗传过程的失调涉及组蛋白甲基化,可导致神经发育障碍,并与精神分裂症(SCZ)和自闭症谱系障碍(ASD)有关。编码赖氨酸去甲基酶 4C(KDM4C)的基因中的变体被认为会增加这些疾病的风险。然而,KDM4C 的罕见遗传变异尚未得到充分评估,并且尚未使用患者来源的细胞研究这些变体的功能影响。在这项研究中,我们在日本样本集中进行了拷贝数变异(CNV)分析(2605 例 SCZ 和 1141 例 ASD 病例,以及 2310 例对照)。我们发现 KDM4C 的 CNV 与 SCZ(p=0.003)和 ASD(p=0.04)之间存在显著关联的证据。我们还观察到 KDM4C 缺失与 SCZ 之间存在显著关联(校正后的 p=0.04)。接下来,为了探讨 KDM4C 中的单核苷酸变异的贡献,我们在第二个样本集中对其编码外显子进行了测序(370 例 SCZ 和 192 例 ASD 病例),并检测到 18 个罕见的错义变异,包括 KDM4C 的 JmjC 结构域内的 p.D160N。然后,我们在第三个样本集中(1751 例 SCZ 和 377 例 ASD 病例,以及 2276 例对照)对 p.D160N 进行了关联分析,但没有发现与这些疾病的统计学关联。使用具有 KDM4C 缺失的淋巴母细胞系进行免疫印迹分析显示 KDM4C 蛋白表达减少和组蛋白甲基化模式改变。总之,这项研究加强了 KDM4C CNV 与这两种疾病之间的关联证据,以及它们对组蛋白甲基化模式的潜在功能影响。